Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
RELAX!!! You must look at GTCH's patent portfolio! Does what they have fix a problem? Does it look desirable by other ai tech autonomous medical companies? Are they generating value for the company? Are their financials up-to-date so that they are ready to be taken over? Is the CEO a pumper? Ask yourself these questions and when the stars start to add up, buy/hold your position and watch the SP go up in time despite any negative banter you hear or read. This company has the goods to satisfy me, if they don't for you, sell to me on the bid please. Relax, we will be ridiculously compensated for our faith in the company. Just my opinion.
Way way way under the radar. One thing to be careful of, do not let the appearance of silence in the public domain on a publicly traded company form a gauge in your mind as to the massive potential financial outcomes of anything. The online silence and the massive accumulation of stock is one of the main reasons I took a position here. THIS WILL CHANGE IN THE NEAR FUTURE I BELIEVE. ;)
…and there it is. Great update. We were looking for news, and we got it! Company is clearly not trying to pump $$ which is very refreshing. The two deals they have recently done are worth roughly $70 million and no figures are provided. You have to dig into the financials to see it hiding in there. Now some of that is restricted stock in TREN but I have high hopes for that company! and BNIX!! I love it. This will pop and pop fast!!!!!!!
Do your homework. CEO has absolutely no intentions, and does not want to do a R/S! Plus, they won’t need to. Good days ahead.
Exactly! Patience and make bank!
We should all be posting on Twitter about Gtch. It’s looking quiet in there which indirectly doesn’t help the cause.
Would love to see a screenshot here of the large buy order near the end... Awesome
Great Dip Buy at this level with what alllll the company has going on with their patents. Doing millions of dollars in deals peeps! Dont panic. Volume is ROCKING!!
These types of games will occur just as they did in those early days of Tsnp remember?? Lock n load!
I remember a stock a couple years back, RLFTF that ran from low of.015 cents (52 week low) climbed to a high of.95 cents!!. This ticker has about 2.9 billion OS, and has little revenues, currently working on their unbelievable patent portfolio, one of which is getting brought into a SPAC deal re Autonomous vehicle Co. I am hoping for a reverse merger with GTCH and a number of candidates - pick one!
And then look at these reverse mergers plays and the meteoric PPS rise. Anything is possible, and within the realms of possibility.
GO GTCH!!! Do what TSNP did - I think you will... shhhhhhhh...
This is going to .05 cents!!!! The technology is OVER THE TOP and us investors are really only cluing into it now. The giant has awoken.
More Intel here on GTCH. Great article and video. Must read & watch!!! Can’t sleep!!
https://ca.news.yahoo.com/ai-eye-podcast-gbts-cto-123000720.html
There are getting more the 45 Million!! The other deal with "TREN Innovation Holdings Inc. ..WHICH WAS BURIED IN THEIR RECENT 10k !!! Is worth $37,000,000 of restricted stock in TREN which is trading on the Nasdaq at $1.45 - take a look.
Here is the blurb regardless buried at the bottom of their recent 10K. Look it up in the public domain Or see below...
Then start to think.... Did GTCH put out a PR about this and the restricted stock they received for the Avanti-AI deal??? Ahhh NO - not that im aware of or, NOT YET!!! Then, go back and look at the stock chart for GTCH and pay attention to the 2 major volume bars over the past 2 trading days and say to yourself, hmmmmm i think somethings up. Friggin right something is up - hello??
BTW, if you're on Twitter, get active. I swear its quiet there because investors are/will try to take their positions before spreading the word on Twitter! Too funny - and typical.
Cheers!
______________________________
On April 3, 2023, GBT Tokenize Corp. (“Seller”), a subsidiary that is owned 50% by GBT Technologies, Inc (“GBT”) entered into an Asset Purchase Agreement (“APA”) with Trend Innovation Holdings, Inc. ( “TREN”), in which GBT consented, pursuant to which Seller sold certain assets relating to proprietary system and method named Avant-Ai, which is a text-generation, deep learning self-training model (the “System”).
In consideration of acquiring the System, TREN is required to issue to the Seller 26,000,000 common shares of TREN (the “Shares”). The Shares will be restricted per Rule 144 as promulgated under the Securities Act of 1933, as amended (the “1933 Act”) and Seller agreed to a lock-up period of nine (9) months following closing (the “Lock Up Term”). In the event that TREN is unable to up-list to Nasdaq either through a business combination or otherwise prior to the expiration of the Lock Up Term, the Seller may request within three (3) business days of the expiration of the Lock-Up Term, that all transactions contemplated by the APA be unwound.
In addition, TREN, Seller and GBT entered into a license agreement regarding the System, granting the Seller and/or GBT a perpetual, irrevocable, non-exclusive, non-transferable license for using the System to be used in its own development, as in-house tool, where Seller or GBT may not sublicense its rights hereunder to any customer or client.
OK, so thats from their recent 8K. Nopw, this is from their recent 10K !! Its buried in there, you have to dig deep. NO PR FROM GTCH ON THIS i would add (Nice...) Both these deals on paper via shares in said companies, worth ************ $80,000,000 *********** Thats 80 million folks! And that just on 2 patent deals. One from TREN & one from BNIX.
Here is the verbiage from the 10K as follows......
On April 3, 2023, GBT Tokenize Corp. (“Seller”), a subsidiary that is owned 50% by GBT Technologies, Inc (“GBT”) entered into an Asset Purchase Agreement (“APA”) with Trend Innovation Holdings, Inc. ( “TREN”), in which GBT consented, pursuant to which Seller sold certain assets relating to proprietary system and method named Avant-Ai, which is a text-generation, deep learning self-training model (the “System”).
In consideration of acquiring the System, TREN is required to issue to the Seller 26,000,000 common shares of TREN (the “Shares”). The Shares will be restricted per Rule 144 as promulgated under the Securities Act of 1933, as amended (the “1933 Act”) and Seller agreed to a lock-up period of nine (9) months following closing (the “Lock Up Term”). In the event that TREN is unable to up-list to Nasdaq either through a business combination or otherwise prior to the expiration of the Lock Up Term, the Seller may request within three (3) business days of the expiration of the Lock-Up Term, that all transactions contemplated by the APA be unwound.
In addition, TREN, Seller and GBT entered into a license agreement regarding the System, granting the Seller and/or GBT a perpetual, irrevocable, non-exclusive, non-transferable license for using the System to be used in its own development, as in-house tool, where Seller or GBT may not sublicense its rights hereunder to any customer or client.
Exactly!!!!! Best post of the day. Now why wouldnt a company like GBT put that out in a PR??? They dont care, their not pumping this. They are low key but its up to investors like us to be INVESTIGATORS and find this stuff out and post it here!!! The news about Trend Innovation I found at the very bottom of their recent 10K. You have to dig for these types of intel if you want to be the early bird folks! The street still hasnt figured this out BUT, over the weekend when investors find this out, Monday will look different I bet! AM I MISSING SOMETHING?? Looking forward to monday.
It wouldnt surprise me if there was another PR after the close, setting up for that .003 Monday or higher. Thats my gut.
Look at the chart for GMZP, look at the volume early March 2023. Thats what Im talking about. Heads up for Monday!!
No matter what this stock does today between .001 and .002, ITS THE VOLUME YOU MUST MUST MUST PAY ATTENTION TOO !!!! Look at the chart over the past 2 years, when your eyes hit those 2 tall green vol bars from yesterday and today, start to rub your chin and look like you just figured out the pyramids!!!!! I have bought many of these with spike volumes and a month later, i'm booking another vacation!!
Its true folks!!!
Sell your dogs and buy GTCH. You will indirectly be owning A.I Patents :)
2 years ago today, this stock was trading around $1.20. This is what shorts like to do. Now, we go up in time. Fun to watch. These guys arent building a CBD weed dispenser!! That are using their intilect and creating A.I patents!! THIS IS WHERE THE MONEY WILL BE. A.I is where the money will be made in the markets, similar to what cannabis did. You know the deal. Buy Low - Sell high! Enjoy!!
Don't let the sells at .11 scare you, a common tactic done by MM's to scare the weak into selling. Then power hour - she pops! The stock is HEAVILY under accumulation here. Something is definitely up. I love SPAC deals!!!! More going on here then we think. Next week .006 X .007 !!
Ignore the shorts here who have had their way too long BECAUSE they were in the dark! Zero plans for a R/S, call the company!!!!!!!!!!!! This stock is heading right to a penny in the next 2 weeks. The amount of cash that GBT is harvesting for their AI patents is SICK and not reflected in the current SP! Apollo software by GTCH for autonomous vehicles that will be manufactured by Bannix which trades at 10 bucks but is a SPAC shell waiting to be taken over. Even that is probably a buy! More patents in the works and subsequent patents to support tghese current patents. This is a tight tight ship and these guys know what they are doing! Again, GTCH is WAY undervalued IMHO. I believe these guys want to get off the pinks as well. MAKE SOME CALLS PEOPLE - YOU WILL FIND OUT IM RIGHT!!
I agree with everything said here, this one is loadable, hide it away, and come back at the end of the summer and you just might see this at .085 cents! More going on here behind the scenes then we realize! This is not your average/typical weed play, there is science going on here. Plus, low float AND... this thing trades on the OTCQB!!!!!!! Oh ya, buy and hold PHBI and reap the rewards that I strongly feel lay before us if we are patient.
Keep your eyes peeled here on PharmaGreen!
Head and shoulders forming. On high alert I would say. I’m waiting for some positive news here that could shoot this up.
Let’s go PHBI !!!! You’ve done it before, you can do it again!
PHBI is a buy in my opinion at .01!!! UNREAL minor sell off. Weak hands! Their loss. The company has many irons in the fire to actually create real revenues. This wuill move back up.
I heard this is about to pop! Anyone know what the dealio is here? Weed stocks poised for growth this summer. This worth buying? I do not like missing a run up. Hello?
Any moment, this could pop to .002. Also, for chits and giggs, take a look at a stock chart (selloff) on ATMO up in Canada. Unreal drop off!! dead cat bounce maybe? Not in. Might..
If you don't think this is being accumulated for a purpose... then go back to bed. Held down on purpose by MM's for smart accumulation before this spikes a tall candle on us, then stabilizes before the bigger run. Low float here, no brainer, waiting for news on new talent and possible acquisition. Willing to wait here, don't be left behind. Dig in.
Dont forget the upcoming involvement of FDBL into the NFT space! FanPassCrypto could really put things in perspective as mentioned in Friendable's PR dated April 2021. This NFT platform is still percolating at HQ im sure. Huge potential here. Once the share price manipulation is done and the nervous nellie shareholders are gone and sold out, watch the fireworks! FanPass is creating revenue people!!! Wake up :)
FDBL is eventually going to run just like CELS & TSOI did you watch! This trades on the PINKs as we all know and it would not surprise me if FDBL management want to get this trading on the OTCQB this year, just a huntch.
Once the debt holders are gone and I bet they are almopst done, this will run - just like CELZ in Christmas of 2020 and TSOI in early 2021. It may be that some of those low float loving investors are piling in here over the past few weeks.
Crazy not to be quietly loading here, stash it away and wait for the upcoming run, because that pop to a penny plus will be upon us faster then you think! This selling......will slow down.... get in the loop!!!
Eyes wide open...
This may be turning around on watch.
People, play the chart! Forget the outstanding shares/billions/etc/etc, LOOK AT GMEV'S CHART! I have played these for years. Always watch for the fall off from highs, watch the volume and look at the sector (weed & growing techniques + patents) - ALL SEXY HERE!!!! Buy this - hold it - be patient - make 300% - move on. BUT, always look at these charts - screaming buys! This will be back to .0035 soon just watch. Dilly
Get this while you can because, like LTNC, this one is going to fly. Shorts have spread their BS far to long here and they will need to purchase shares to cover their short positions and that my friends, is why this is heading right to .05.
Keep your wits about you here boys. You are going to witness a TEEN Ager here move into adulthood here. .35 has always been a good age.. Major run setting up. Enjoy!
Read this. Best post of the month. Change your zip code people!!! This stock is about to catapult to new highs! Give this 30 days and you could be sitting at $.25! There may be a buyout deal being worked out here. The share price is skyrocketed from a month ago. They may even be trying to get their share price up to move up to the OTCQB for better exposure.
A key factor to this company is is Dr. Thomas Ichim. Please read Thomas Ichim's Bio here:
Thomas E. Ichim founded 5 companies, among them: ToleroTech Technology, Inc., MedVax Pharma Corp. and Biorasi LLC. Presently, Dr. Ichim holds the position of Director & Chief Scientific Officer at Nobilis Therapeutics, Inc., Chief Scientific Officer & Director at Creative Medical Technology Holdings, Inc., President & Director at Creative Medical Technologies, Inc. (a subsidiary of Creative Medical Technology Holdings, Inc.) and Director & Chief Scientific Officer at Batu Biologics, Inc. (which he founded in 2014). Dr. Ichim is also on the board of Therapeutic Solutions International, Inc. and Riordan Clinic and Director & Vice President at Creative Medical Health, Inc.
In the past Thomas E. Ichim was Director & Chief Scientific Officer at Regen Biopharma, Inc., Vice President-Cellular Therapies at Intrexon Corp. and President, Director & Chief Scientific Officer at Medistem, Inc. (a subsidiary of Intrexon Corp.) and Program Manager at Biorasi LLC (he founded the company in 2004).
By the way, Medistem was bought by intrexon in 2014
https://www.prnewswire.com/news-releases/intrexon-completes-acquisition-of-medistem-248984811.html
And Dr Thomas Ichim was the chief KOL and insider of medistem . At that time medistem insiders were holding 80% of restricted common shares too. TSOI IS SITTING ON A TON OF RESTRICTED SHARE!! Same method of operation as before. TSOI IS GOING TO NOT ONLY RUN TO $1.50 LIKE MEDISTEM DID, ITS GOING TO GET BOUGHT OUT! It’s been said here in the public domain that the number one company that could take them out could be Gilead Sciences Inc.
TSOI is following the same path as Medistem. The Company is making a lot of progress under the radar BUT PEOPLE NEED TO SEE THE LARGER PICTURE. LEARN FROM THE PAST PEOPLE! TSOI & MEDISTEM = Same M.O - (Method of operation)
Here are all the facts. No pump intended. There are too many great things happening at TSOI, and now it is just a question when it will be bought by a big biopharma co.
Good luck to all.
I think this stock is set to catapult to .05 ! The chart has worked perfectly from 006. I like the fact that management is buying shares even two days ago. Got to love that. Did these guys know something that we don’t? I might hold the majority of my position all the way up to Medistem prices. If you think CELZ had a run to .048, you haven’t seen anything yet. Buckle up people.
Long post sorry - BUT ...I just jumped into TSOI last week and I am going to stay here for a while. Stem Cell Science is going to take off in 2021 & 2022! Why?? Because of all the Covid-19 investigations that have been going on, and the importance of stem cell therapy when aiding the sick. Anyways, look what I dug up today which is awesome for TSOI - Big Time!
As I read in yesterdays TSOI news they put out, this Dr. Marincola which is now an advisor to TSOI, is world renound; Top Notch in his field. How about this people, HE JUST GOT HIRED YESTERDAY BY, are you sitting down..., GILEAD SCIENCES to head up one of their divisions!! Huge Scientific Immunotherapy Company here in the U.S! ( NASDAQ - $67.23 per share ) The synergies that could exist between TSOI and Dr. Marincola are massive! Why is Dr. Marincola even waisting his time acting as an advisor??? HE SEES THE POTENTIAL IN TSOI!! He probably hangs in the same wheel house as TSOI s Dr. Ichim perhaps. Also, Dr. Santosh Kesari, another TSOI advisor, is top top shelf in stem cell immunotherapy from what i see!
Look :
by Ben Adams | Jan 19, 2021 9:20am
AbbVie and National Institutes of Health (NIH) veteran Francesco Marincola, M.D., will become Gilead’s new head of cell therapy research out of its Kite unit.
He replaces Peter Emtage, Ph.D., who quit the company a few months back for a foray into venture capital work at Versant.
Marincola’s official role as senior vice president and global head of cell therapy research puts him right at the center of an exciting new approach to treating blood and, increasingly, some solid cancers, though it's been fraught with technical difficulties, safety woes and increasing competition.
His role becomes effective Feb. 1, and he will lead all of Kite’s research organization across hematological malignancies and solid tumors. Gilead bought Kite for around $12 billion four years ago, hoping to create a latent to nascent cancer research unit that can build on its infectious disease success.
Kite itself has been ramping up the deals over the years to add better technology and tweaks to its cell therapy platform, while also expanding outside of blood cancers and into the much trickier realm of solid tumors.
Kite is one of a leading pack of companies with approved CAR-T drugs Yescarta and Tecartus, though it is hoping to expand the indications for these therapies while also working on earlier experimental efforts with KITE-718 and KITE-439, both of which are in early trials for solid tumors.
RELATED: Gilead's Kite taps Teneobio to build next-gen CAR-Ts for multiple myeloma
“Franco’s proven track record in oncology and robust research experience that spans the NIH to industry will be critical to the targeting and acceleration of our research efforts in CAR T and beyond,” said Christi Shaw, CEO at Kite.
“As the cell therapy leader, we are thrilled to welcome Franco to our team and are confident that his exceptional skills and expertise will best position our research to discover potentially life-saving therapies for patients in need.”
Marincola joins Kite from Refuge Biotechnologies, where he was president and chief scientific officer, working on its synthetic biology strategies for adoptive cell therapy products and lead programs based on nuclease-deactivated CRISPR circuits.
He is also an NIH-tenured senior investigator in cancer immunotherapy and biomarker research and spent 23 years at the NIH. Previously, he served as a research fellow in immuno-oncology discovery at AbbVie.
“It is an honor to bring my experience to an industry-leading team that is working to make cell therapies with curative intent available to patients,” added Marincola. “I look forward to helping build and diversify our research efforts in support of this mission.”
-----------------------------------------------------------
H U G E I N T E L ! This will not be trading sub penny much longer. Potential 25 X runner here - straight up!! TSOI has way more going for it then CELZ in my opinion, but TSOI has not been discovered yet! Big potential here & zip code changer if you play this right, value the science, and hang on to your TSOI stock for a while.
Cheers
When somebody checking into the stock sees the chart, they get freaked out because they don’t want to buy at the high. But what they fail to do is back away from the chart, way out, way way out, and basically see that it’s hovering around a penny and has plenty of room to move north, which is what exactly will happen here. So much going on behind the scenes here. This will be at a dime very quickly.
Court proceedings involving Pharmagreen. Just be careful that’s all.
Plus,15 million shares have been added to the float between the 7th of January & 15th January 2021. Check OTCBB.com. Someone is diluting for cash. Hmmm.
https://www.docketbird.com/court-cases/Ema-Financial-LLC-v-Pharmagreen-Biotech-Inc/nysd-1:2020-cv-05662
01/15/2021NOTICE OF APPEARANCE by Nicole Ann Sullivan on behalf of Pharmagreen Biotech Inc.